Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid
OSNA
Application of the One-step Nucleic Acid Amplification (OSNA) Assay to Detect Free Cancer Cells in the Peritoneal Washing of Gastric and Colon Cancer Patients
1 other identifier
observational
108
1 country
1
Brief Summary
In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFirst Submitted
Initial submission to the registry
March 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedMarch 20, 2026
March 1, 2026
1.3 years
March 12, 2026
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of both traditional cytology and OSNA assay to detect free cancer cells in the peritoneal fluid of patients with gastric or colon cancers.
The OSNA assay was defined positive if at least a numer higher 160 cCP/µL was detected.
The OSNA technique requires almost 30 minutes. Follow-up time of patients has a mean of 15 months.
Study Arms (1)
Gastric and colon cancer patients without macroscopic peritoneal diffusion
Examination of peritoneal washing with both traditional cytology and OSNA assay
Eligibility Criteria
University
You may qualify if:
- Gastric and colon cancer patients with no evidence of peritoneal carcinomatosis undergoing surgery
You may not qualify if:
- Oncological patients with overt peritoneal diffusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Campania "Luigi Vanvitelli"
Naples, Campania, 80131, Italy
Related Publications (4)
Geca K, Skorzewska M, Rawicz-Pruszynski K, Mlak R, Sedlak K, Pelc Z, Malecka-Massalska T, Polkowski WP. Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients. Sci Rep. 2022 Jul 21;12(1):12477. doi: 10.1038/s41598-022-16761-8.
PMID: 35864130BACKGROUNDGalizia G, Lieto E, Auricchio A, Cardella F, Mabilia A, Podzemny V, Castellano P, Orditura M, Napolitano V. Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer. Dis Colon Rectum. 2017 Dec;60(12):1273-1284. doi: 10.1097/DCR.0000000000000961.
PMID: 29112563BACKGROUNDKong D, Li Y, Yin S, Tan Y, Qu B, Huang L, Xi JJ, Wu A. Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Patients with Stage II-III Colorectal Cancer. Ann Surg Oncol. 2025 Dec;32(13):9712-9722. doi: 10.1245/s10434-025-18176-x. Epub 2025 Sep 1.
PMID: 40887569BACKGROUNDSugiyama Y, Tanabe K, Yanagawa S, Tazawa H, Toyota K, Kano M, Misumi T, Shishida M, Okano K, Hotta R, Ota H, Imaoka Y, Fukuda T, Takahashi S, Ohdan H. Prognostic factors and efficacy of postoperative chemotherapy in patients with gastric cancer with positive peritoneal cytology after gastrectomy. World J Gastrointest Oncol. 2025 Sep 15;17(9):110245. doi: 10.4251/wjgo.v17.i9.110245.
PMID: 40977665BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gennaro Galizia, MD
University of Campania Luigi Vanvitelli
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 23 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Surgery
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 17, 2026
Study Start
July 1, 2024
Primary Completion
October 31, 2025
Study Completion
February 28, 2026
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- one month after publication
- Access Criteria
- email gennaro.galizia@unicampania.it
all data will be shared after publication